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Expression of cell surface antigens such as viral proteins, differentiation
markers (TL, Lyt), and tumor-specific transplantation antigens (TSTA), has been
intensively studied on murine tumor cells (for reviews, see references 1-3) .
Abnormal expression of the major class I histocompatibility antigens (in brief,
H-2 antigens in the mouse) has often been observed in spontaneous and virio- or
chimio-induced tumors (4-6) . In certain instances, expression of new H-2 speci-
ficities has been reported (7-9) . In others, there was no change in serological
specificities, but quantitative differences in the expression of the products of the
H-2D and H-2K loci were detected-sometimes an increase in expression but
generally either a decrease of both K and D products, or a selective decrease of
K alone (5, 6, 10) . Such anomalies have most often been described in hemato-
poietic (lymphoid and erythroblastic) tumor cells, but have also been reported in
solid tumors induced by methylcholanthrene (11) . Decreased H-2 expression is
particularly frequent in leukemias appearing in AKR mice and erythroblastoses
induced by Friend virus . It has been suggested that in some cases the decrease
in H-2 antigen at the cell surface could be due to antigen masking at the cell
membrane (12) . H-2 heavy chains could also be present in the cytoplasm and not
be exported to the surface, as happens, by lack of active (2-microglobulin ((02 -
m), in human Daudi cells (13, 14) . There has also been reported a loss of H-2
expression in cells that have been maintained for many generations in vitro (15,
16) . This in vitro modulation of H-2 expression is reversible and after one
passage in vivo, the H-2 antigens can be redetected at the cell surface .
Cloned molecular probes corresponding to H-2 and(32-m gene sequences have
become available in this (17-19) and other laboratories (for review, see reference
20) . H-2 and X32-m genes and their transcripts can thus be analyzed in these
pathological situations, a study that has not been carried out before . We have
shown earlier that some tumors induced by Moloney murine leukemia virus (M-
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MLV) have an altered H-2 expression (21). We selected a number of such tumors
and demonstrate here that in at least some of these tumors, abnormal expression
is related to a reduced amount of H-2 mRNA. In one case, an important decrease
in the quantity of H-2 mRNA is correlated with the absence of detectable cell
surface antigens coded by several H-2 genes and suggests a common regulatory
defect, perhaps situated at the transcriptional level.
Materials and Methods
Cell Lines.
￿
B4R, BM4R, and BM5R were initially obtained as primary tumors following
injection of Moloney murine leukemia virus (M-MLV) into mice with a B10 background
(see Table I).
Primary tumors were established as continuous cell lines in vitro and maintained in
RPMI 1640 Dutch modification (Flow Laboratories) supplemented with 10% heat-inacti-
vated fetal calf serum, antibiotics, and 5 x 10-5 M /3-mercaptoethanol. They were frozen
in liquid nitrogen after - 1 mo of in vitro passaging. The H-2 typing and RNA extractions
were done at 2-3 mo. In vivo transplantation of these cell lines was regularly obtained by
treating syngeneic mice with pristane (2,6,10,14-tetramethyl pentadecane), 0.5 ml intra-
peritoneally 10 d before intraperitoneal inoculation of 10' cells. Sublethal irradiation
(400 R) was performed 3 d before the cell challenge. In these conditions, all the inoculated
mice developed either ascitic, mesenteric, or splenic tumors within 3 wk.
LSTRA and AIBL2 were initially obtained as primary M-MLV-induced tumors in
BALB/c and C57BL/6 mice respectively (27). They were maintained as ascitic tumors
by serial in vivo transplantation in syngeneic animals. These two cell lines are routinely
used by several laboratories as target cells for T cell-mediated cytotoxicity studies
following inoculation of Moloney murine sarcoma virus. They were, therefore, used as
H-2-positive control lymphoid cells.
H-2 Typing.
￿
H-2 antigen expression on cell lines was initially studied by microcytotox-
icity assay using conventional H-2 antisera, (reagents 1-4 in Table 11). The monoclonal
antibodies 20-8-4S, 28-14-8S, 11-4- 1, and 34-2-12 were kindly provided by D. Sachs and
K. Ozato (National Cancer Institute) (23-25) . These antibodies were also used to confirm
the H-2 antigen expression by immunofluorescence. The H-2' expression was verified by
absorption of the antiserum at one dilution above the 50% cytotoxic value on B10M
splenocytes. Absorbed antisera were retested on BIOM lymphoid cells. The anti-TL
antiserum was kindly provided by F. W. Shen (Memorial Sloan-Kettering Cancer Center,
New York).
DATA and RA'A Extractions. DNA was extracted from mouse tissues or cell lines as
described by Gross-Bellard (26). RNA was extracted with lithium chloride and urea,
according to Auffray and Rougeon (27). The polyA+ mRNA was purified on oligo-dT
cellulose columns (19).
°Souther)7" airxl "Northern" Blottiizgs.
￿
The high molecular weight DNA was cleaved with
different restriction enzymes in conditions recommended by the manufacturer (New
TABLE I
Mouse Strains and Derived Tumors Cell Lines
Strain Tumor
BALB/c KdDd LSTRA
C57BI/6 KbDb MBL2
BIO.A(4R) K"Db B4R
F, BIOM x BIO.A(4R) K"Db/KFDF BM4R
= BIOM x 4R
F, BIOM x BIO.A(5R) KbDd/KFDf BM5R
= BIOM x 5R1296 ALTERED TRANSCRIPTION OF H-2 GENES IN TUMOR CELLS
TABLE 11
Serological Reagents
Results
England Biolabs, Beverly, MA). 20 kg of cleaved DNA per slot was subjected to agarose
gel electrophoresis and then transferred to nitrocellulose paper, as described (28). North-
ern blots were carried.out according to Thomas et al. (29), as described previously (19).
Relative amounts of H-2 RNA sequences were estimated in a dot blot assay by directly
applying 400 ng to 4 ng of poly A+ RNA or 40 ug to 0 .4 Ag of total RNA to the
nitrocellulose filter. The filter was hybridized to the H-2 probe in the same conditions as
for the "Northern" blots.
Serological Analysis of Tutnor Cells.
￿
We have selected for analysis three thymo-
mas, named B4R, BM4R, and BM5R, isolated as described in Material and
Methods and deficient in the expression of H-2 antigens at the K and/or D
locus. B4R, BM4R, and BM5R were isolated to B10 recombinant genetic
backgrounds, homozygous (B4R) or heterozygous (BM4R and BM5R) at the H-
2 region (Table I) . For comparison, we used two other lymphomas, also induced
by M-MLV, named LSTRA and MBL2, which are known to express the products
of both H-2 regions (22) (E. Gommard, personal communication).
For serological typing, B4R, BM4R, and BM5R cells were grown in culture
from the primary tumor for no more than 8-12 wk and analyzed by complement-
mediated cytotoxicity and immunofluorescence, using reagents listed in Table
II . In most cases, these results were confirmed by absorption of specific sera on
tumor cells, splenocytes, and thymocytes and retested on target splenocyte cells.
(Some tests were also performed on the tumors grown in vivo) . Results are
summarized in Table III .
The H-2 + tumor cells taken as controls, LSTRA and MBL2, were respectively
negative and positive for Thy-1-2 . B4R, BM4R and BM5R were Thy-1-2 positive,
in agreement with their thymic origin . However, B4R, BM4R, and BM5R have
abnormal H-2 expression : B4R (from a homozygous background H-2KkDb) does
not express Kk but retains expression of Db; BM4R (from a heterozygous
background H-2KkDb/H-2r
) has lost expression of Kk and Db while retaining H-
Reagents Antibody specificity
Alloantisera
Donor lymphoid
cells Recipient strain
1 a H-2d BALB/c (C3H x BALB.B)F1
2 a H-2 k BALB.K (B6 x BALB/c)Fl
3 a H-2 b BALB.B (C3H x BALB/c)F1
4 a H-2' B10M BIO.W.B.
5 a H-2 b B10 B10.BR
6 a TL, 1, 2, 3, 5 & Qa-1 ASL1 (B6 x A.Tlab)F1
7 a Thy-1-2 Thymus C3H AKR
Monoclonal antibodies
8 = 20-8-4S a Kb, Db, Kd, r, s C3H-SW C3H
9 = 28-14-8S a Db, Ld, q C3H-SW C3H
10 = 34-2-12 a Dd BDF1 C3H
11 = 11-4-1 a Kk, K9, p, r CKB BALB/cBALDACCI ET AL.
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2` expression; BM5R (from a H-2KbDd/H-2f heterozygous background) is nega-
tive for H-2K6 and H-2Dd and H-2f. Absorption experiments were especially
necessary with the anti-H-2' serum. As the immunizing lymphoid cells from
B lOM mice are known to produce spontaneously endogenous MLV, the serum
may contain antiviral activity. In fact, BM4R and BM5R were both positive by
direct cytotoxicity . However, absorption experiments showed that BM4R was H-
2f-positive while BM5R was H-2f-negative.
The nonexpression of the H-2 regions for the three tumors was verified by
measuring their immunofluorescence with different antisera in a fluorescence-
activated cell sorter (Cytofluorograph 50HH, Microprocessor MP 2000; Ortho
Diagnostic Systems, Westwood, MA) (see Table III). Background values obtained
confirmed that B4R is Kk-/Db+, BM4R is Kk-/Db- , and BM5R is Kb-/Dd-.
Therefore, it seemed to us that B4R, BM4R, and BM5R were good candidates
for representing cell lines with altered H-2 expression : at the H-2K locus of both
chromosomes (B4R); at the H-2K and H-2D loci of one chromosome, while
retaining expression on the other (BM4R); at the H-2 regions of both chromo-
somes (BM5R). Particular attention was paid to the latter tumor, which was
analyzed upon both in vivo growth in the animal and in vitro culture of tumor
cells. Serological analysis on both the in vivo and in vitro propagated tumor did
not indicate any modulation in H-2 expression related to the mode of propagation
and this observation was further assessed by the analysis of genes and transcripts.
Analysis ofH-2 Genes and ofthe ,o2-in Gene.
￿
For determining whether H-2 and/
or ,Q2-m genes have been deleted in tumor cells, or rearranged in any way that
could account for abnormal expression, we analyzed tumor DNA by Southern's
technique (28).
The H-2 probe used was the 610 by long HinfI-HinfI fragment of plasmid
pH-2d-4 (18). It corresponds to a portion of an H-2 cDNA coding for the third
TABLE III
Serological Analysis of Tanior Cells.
Method ofDetection ofH-2 Determinants.
* Tests were performed on cells grown in vivo and in vitro.
.\'T, not tested.
Complement-mediated
cytotoxicity
Absorption
of serum
Immunofluo-
rescence FAGS
B4R H-26 + 3 NT + 9 + 9
K°-Db+ H-2° - 2* - 2* - 11 - 11
Thy-1-2 + 7 NT NT NT
TL + 6 NT NT NT
BM4R H-26 - 3 - 5 - 9 - 9
K°-Db- H-2° - 2 NT - 11 - 11
H-2f+ H-2f + 4 + 4 + 4 NT
Thy-1-2 + 7 NT NT NT
TL + 6 NT NT NT
BM5R H-26 - 3 - 5 - 8 - 8
Kb-Dd- H-2d - 1 - 1 - 1 10 - 10
H-2f- H-2f + 4 - 4 - 4 NT
Thy-1-2 + 7 NT NT NT
TL + 6 NT NT NT1298
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extracellular domain, transmembrane and cytoplasmic regions of H-2 heavy
chains . It has been shown earlier that this probe (or probes similar to it) detects
many restriction fragments in the mouse genome, in relation to the fact that H-
2 genes belong to a relatively large multigene family, which comprises at least
36 members in BALB/c mice (30-32) . The X32-m probe was the 685 by long
HhaI-HhaI fragment of plasmid pat-ml (19) . In contrast with the H-2 probe, the
a2-m probe reacts with only a few fragments in the mouse genome, the interpre-
tation of data being consistent with the existence of a unique X32-m gene (33) .
For the Southern analysis, DNA from each type of tumor was compared with
DNA of the parent mouse, using several restriction enzymes .
Fig . 1, A shows EcoRI digests of DNA extracted from BALB/c liver and
LSTRA (lanes a and b) and B10.A(4R) and B4R (lanes c and d, respectively),
hybridized with the H-2 probe . Fig . 1, B shows BainHI digests of DNA from
C57BL/6 liver and MBL2 (lanes a and b) as well as BIOM X 5R (liver and
thymus and BM5R tumor cells (lanes c, d, and e, respectively) . Fig . 2, A shows
MspI digests from BioMX5R liver and thymus (lanes a and b), BM5R grown in
vivo (mesenteric lymph node) (lane c) or in vitro (lane d), as well as BIOM X 4R
liver (lane e) andBM4R tumorDNA (lanef). Again, BALB/c (liver and thymus)
andLSTRA DNA, as well as C57BL/6 (liver and thymus) and MBL2 DNA were
used as controls (Fig . 2, B, lanes a, b, c, d, and e, respectively) . In all cases, patterns
of hybridization of tumor DNAs were of similar complexity to those of the
parent animals and no difference could be detected .
FIGURE 1 .
￿
Southern blot analysis of H-2 genes with EcoRI and BarnFIL (A) EcoRI digested
DNAs from BALB/c liver, LSTRA, BIO.A(4R) liver, and B4R mesenteric lymph node (lanes
a, b, c, and d, respectively) . The samples (20 jug) were run in 0.7% horizontal agarose gels,
transferred to nitrocellulose filters, and hybridized to 50 ng of nick translated H-2 probe
(specific activity about 2.108 cpm/ug). Sizes of DNA marker fragments (XDNA digested with
HindII1) are indicated in kilobase pairs (kb) . (B) BamHI digested DNAs from C57BL/6 liver,
MBL2, BIOM x 5R liver, BIOM x 5R thymus andBM5R mesenteric lymph nodes (lanes a, b,
c, (1, and e, respectively), hybridized to H-2 probe .BALDACCI ET AL .
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FIGURE 2.
￿
Southern blot analysis of H-2 genes with MspI . (A) MspI digests of DNA from
BIO x 5R liver, thymus, BM5R mesenteric lymph nodes, BM5R cells grown in vitro, B10M
x4R liver, BM4R ascitictumor (lanes a, b, c, d, e, andf, respectively), hybridized to H-2 probe
as described in Fig . 1 . (B)MspI digests ofDNAfrom BALB/c liver, thymus, LSTRA, C57BL/
6 liver, and MBL2 (lanes a-e) hybridized to H-2 probe .
We examined more closely, in two respects, the DNA of the seemingly H-2-
negative tumor BM5R . First, we analyzed the state of methylation of H-2 genes
using MspI and Hpall restriction enzymes . These enzymes restrict DNA at the
same site, except that HpaII does not cleave when the CpG in the site is
methylated (34-36) . Results in Fig . 3, A reveal no drastic difference between
liver DNA from the parent animal and the DNA of BM5R grown in vivo or in
vitro (digested with EcoRI and MspI, lanes a, c, and e; digested with EcoRI and
HpaII, lanes b, d, andf ) . Second, we looked for the ,Q2-m gene with the #2-m
probe . Results in Fig . 3,Bshow the presence of the characteristic 2.8-kb and 6-
kb EcoRI bands (33) in B10M X 5R liver and thymus (lanes a and b) and BM5R
DNA (lane c) . Similar results were obtained with other tumors (data not shown) .
In summary, these experiments have detected no structural change, either in
the H-2 multigene family or in the (32-m gene, that could account for the altered
expression of H-2 in tumor cells.
Transcription? of the ,02-1u and H-2 Genies iii Tumor Cells.
￿
Transcription of the
,02-m and H-2 genes was assayed with the same probes as above, using the
Northern hybridization technique (29) . The H-2 probe is known to detect a
major RNA band, corresponding to molecules of ^-1,800 nucleotides, which
contains the transcripts of class I genes . Although this H-2 probe probably detects
transcripts of all the class I genes, K, D, L, Qa, and TL, the majority of the
transcripts that hybridize are from the K and D regions as theanalysis of acDNA
bank, made in the laboratory from DBA/2 liver mRNA, has shown that 30% of
the clones positive with this probe were Kd transcripts (J . L. Lalanne, personnal
communication) . This probe can therefore be used to monitor predominantly
the transcripts of the regions Kand D .
The a2-m probe detects two RNA species of about 800 and 1,000 nucleotides1300
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FIGURE 3 .
￿
Southern blot analysis of BM5R DNA for H-2 genes and the ,Q2-m genes . (A)
DNAs from B10 X 5R liver, BM5R mesenteric lymph nodes and BM5R cells grown in vitro
were digested to completion with EroRI plus Mspl (lanes a, c, e) or EcoRl plus Hpoll (lanes b,
(1,J), electrophoresed through 0.7% agarose gels, transferred onto nitrocellulose filters and
hybridized to H-2 probe, as described under Fig . 1 . (B) EcoRI digests of DNA from B10M X
5R liver, thymus and BM5R mesenteric lymph nodes, hybridized to the /32-m probe . The
arrows indicate the characteristic fragments of 2.8 kb and 6 kb of the p2-m gene .
(19, 37) that are due to the presence of two polyadenylation sites in the (32-m
gene (38) .
In the experimentsshown in Fig . 4, the twoprobes were mixed and hybridized
to poly A+ RNA transferred onto a nitrocellulose filter . C57BL/6 andBALB/c
liver RNA display the expected pattern (Fig . 4, A, lanes a and c) . MBL2 and
LSTRA RNA show the expected bands plus additional material ofhigh molecular
weight (Fig . 4, A, lanes b and d) . Hybridization with the H-2 probe alone shows
that these bands of high molecular weight, as well as a band ofRNA of ^-1,500
nucleotides react with the H-2 probe and not the (32-m probe (Fig . 4, B) . Results
obtained with B4R and BM5R and a mixture of the H-2 and R2-tn probes are
shown in Fig . 4, C (lanes b and d) together with control liverRNA from C57BL/
6 and B10M X 5R (lanes a and c) . These tumor cells have reduced amounts of
H-2 RNA, barely detectable in BM5R (lane d) . BM5R, however, does make
significant amounts of a2-m RNA, as seen in lane h, which shows a longer
exposure of lane d. The experiment shows a decrease in the a2-In RNA content,
but less drastic than for H-2 mRNA . One should note, however that only the
1,000, nucleotides mRNA is detectable in this tumor although the mRNA from
the liver shows the two a2-In bands.
These results could be due to a particularly active degradation ofmRNA in
tumor cells . The integrity of RNA preparations was assessed in two ways : (a)
their ability to direct protein synthesis in vitro in a reticulocyte lysate system
(data not shown) ; (b) hybridization with other probes in the same Northern blots,
such as actin, (32-m and retroviral LTR probes (see Fig . 4, D, lane b for
hybridization of BM5R in vitro RNA with an SFFV LTR probe; details are givenBALDACCI ET AL .
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FIGURE 4 . Analysis of H-2 and /32-m transcripts in normal tissues and M-MLV-induced
tumors . (.9) 5 ug of poly A'RNA were treated as described in Materials and Methods and
electrophoresedthrough 1 .1% agarose gels, transferred onto nitrocellulose filters and hybrid-
ized to the H-2 and #2-m probes . Lanes a, b, r, and d contain, respectively, poly A' RNAs
from C57BL/6 liver, MBL2, BALB/c liver, and LSTRA . (B) Poly A' RNAs from LSTRA
(lane a), BALB/c liver (lane b) and MBL2 (lane r) hybridized to the H-2 probe only. (C) Poly
A' RNAs from C57BL/6 liver, B4R ascitic tumor, B10M X 5R liver, and BM5R cellsgrown
in vitro (lanes a, b, r, and d, respectively) hybridized with a mixture of the H-2 and ,Q2-m
probes . Lanes e,f, g, and h correspond to a longer exposure of lanes a, b, r, and d, respectively .
(D) Poly A' RNAs from B10 X 5R liver (lane a) and BM5R cells grown in vitro (lane b)
hybridized to an LTRprobe of SFFV . The LTRprobewas a subclone derived from the SFFV
genome initially cloned by Linemeyer et al . (39) . The SFFV plasmidwas digested to completion
with EroRl and Pstl andthe 1 .8 kb Ero-Pst containing theLTRwas ligated to pBR327 digested
with Ero-Pst (B. Cami, personal communication) .
in the legend). These controls showed that the RNA preparations used were
intact and that degradation, unless extremely selective for H-2 mRNAs, could
not explain the very much reduced amounts of H-2 mRNA in BM5R .
To evaluate the quantity of the H-2 RNA made in the different tumor cells,
we carried out a dot blot hybridization with a series of semi-logarithmic dilutions
of each sample ofRNA (poly A+ or total) spotted on the filter . Comparison of
the intensities of the spots on the autoradiograph (confirmed by densitometer
scanning) permits a semi-quantitative estimate of the relative amounts of H-2-
specific RNA in poly A+ RNA (Fig . 5) . Salient features are that : (a)LSTRA (row
8) makes several times more H-2 RNA (3-10 times) than spleen (row 3) ; (b)1302
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FIGURE 5 .
￿
Estimation of the relative H-2 mRNA abundance in normal tissues andM-MLV-
induced tumors by dot blot analysis . Decreasing amounts of poly A' RNA (400 ng-4 ng) or
total RNA (40 Ag-0 .4 jug) were applied to the nitrocellulose filter and hybridized to the H-2
probe as described in Materials and Methods . Poly A' RNA from C57BL/6 liver, thymus, or
spleen (rows 1, 2, and 3, respectively), BM5R cells grown in vitro or in vivo (rows 4 and 5),
BM4R cells grown in vitro (row 6), B4R grown in vivo (row 7), LSTRA and MBL2 (rows 8
and 9, respectively) . Total RNA from C57BL/6 thymus (row 10) and BM5R cells grown in
vitro (row 11) .
BM5R grown in vitro or in vivo (rows 4 and 5) makes 10-30 times less RNA
than liver or thymus (rows 1 and 2) and 30-100 times less than spleen (row 3) ;
(c) BM4R and B4R (rows 6 and 7) yield intermediates levels ; (d) there is no
detectable accumulation of H-2 sequences in the poly A- RNA of BM5R since
total RNA of this tumor yields very weak signals (row 11) as compared with total
thymusRNA of C57BL/6 (row 10) .
Discussion
We have analyzed three tumor cell lines that display deficient H-2 expression
of either one gene on a homozygous background (B4R) or several H-2 genes
from one or both chromosomes in a heterozygous background (BM4R and
BM5R). TumorDNA and RNA were analyzed with cloned H-2 and ,#2-mcDNA
probes using the Southern and Northern techniques .
DNA analysis reveals no observable difference between genes of the tumors
and of the parent animals . It must be noted, however, that the Southern pattern
of H-2 genes is complex, and that the probe used was characteristic of the 3'
half of H-2 genes and did not detect the 5' half. These experiments, therefore,
suggest strongly that there is no gross deletion or rearrangement of H-2 genes,
but we cannot rule out deletion of one gene and/or rearrangement at 5' ends
or some minor lesions that affect the expression of the H-2 genes .BALDACCI ET AL.
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Analysis of RNA showed a decrease in mRNA hybridizing to the H-2 probe
in these cells correlated with abnormal H-2 expression . Particular attention was
given to BM5R for which serological data suggested an H-2-negative phenotype.
H-2 mRNA in BM5R was very much reduced, while (32-m RNA, albeit dimin-
ished, was easily detected. Lack of ,02-m is, therefore, not the origin of the H-2-
negative phenotype, which is more likely to be due to decreased transcription of
the H-2 genes. The weak signal of hybridization (a few per cent of control) could
be due either to H-2 expression in a small percentage of the cell population, or
to cross-hybridization of the H-2 probe with H-2-like sequences such as those
coding for TI or Qa-1 antigens (20, 40, 41). Preliminary serological data suggest
that BM5R expresses TL antigen, so that we rather favor the latter hypothesis .
In vitro modulation of H-2 expression in BM5R was ruled out by the analysis of
DNA and RNA in tumor cells grown in vivo and in vitro.
Decrease in the expression of H-2 antigens at the surface of tumor cells could
make them insensitive to H-2-dependent and H-2-restricted cellular cytotoxic
reactions and be one of several means favoring tumor progression. In this regard,
growth of tumors in an animal could be a way of isolating or selecting variant or
mutant cells with altered H-2 expression . Ourstudies with different combinations
in the loss of H-2 expression (one locus, both loci of one chromosome, loci of
both chromosomes) give no clue as to a possible common mechanism inactivating
one or several H-2 genes. In particular, all tumors were induced by M-MLV and
our present studies have not revealed viral integration in the immediate vicinity
of H-2 genes which would have altered the Southern patterns (data not shown).
In the first combination (H-2K-D+), there exist somatic cells with the same H-
2 phenotype in a compartment of the thymus (42). B4R tumor cells could,
therefore, derive from the latter. In the other two combinations, there is no
known somatic equivalent. Embryonic cells express neither H-2 heavy chains nor
02-m and neither of these genes is transcribed in embryonal carcinoma cells (19,
37). The situation in BM5R is different, since it expresses significant amounts of
R2-m RNA, but it cannot be ruled out that some embryonic cells have the same
behavior. The fact, however, that BM4R and BM5R are thymomas strongly
suggests that these tumors have acquired their H-2-negative character by some
kind of alteration in the regulation of H-2 genes rather than representing some
immortalized intermediate stage of cell differentiation . Our results would then
point to the existence of a mechanism(s) that coordinately regulates the expres-
sion of distant H-2 genes on oneor both chromosomes. Human cell lines negative
for the expression of class I HLA antigens have been selected in vitro by
Gladstone et al. (43) with similar conclusions (see also reference 44). These
various tumor cell lines could thus provide a useful material to analyze further
this hypothetical regulation of H-2 gene expression .
Summary
Three murine tumors induced by Moloney murine leukemia virus (M-MLV)
which exhibited loss of some or all H-2 class I antigens at the cell surface were
analyzed at the DNA and RNA level with molecularprobes specific of H-2 heavy
chains and X32-microglobulin sequences. No observable difference could be
detected at the DNA level between the tumors and the parent animals. However,1304
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a decrease in H-2 mRNA was observed, especially in phenotypically H-2 negative
tumor, BM5R, where H-2 transcripts were at least 30-fold less abundant. These
results show that an H-2-negative character may result from a general alteration
in the transcription of H-2 genes, which could reflect some kind of regulatory
process.
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